Alyssa H Hasty

28PUBLICATIONS
61CO-AUTHORS
AutoimmunityPredictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Feb 17, 2026
Interrupting T-Cell Memory Ameliorates Exaggerated Metabolic Response to Weight Cycling.

Jamie N Garcia, Matthew A Cottam, Alec S Rodriguez

|Nov 24, 2025
Risk of Coronary Artery Disease Associated With Transitions in Metabolic Health in a Clinical Cohort of 69 272.

Megan M Shuey, Rebecca T Levinson, Megan E Vogel

|Nov 06, 2025
TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Elysa W Pierro, Guadalupe A Garcia, Violeta M Sanchez

|Mar 17, 2025
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression.

Sandesh J Marathe, Emily W Grey, Margaret S Bohm

|Feb 03, 2025
Interrupting T cell memory ameliorates exaggerated metabolic response to weight cycling.

Jamie N Garcia, Matthew A Cottam, Alec S Rodriguez

|Jan 22, 2025
Comparison of Lean, Obese, and Weight-Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T-cell Populations.

Elysa W Pierro, Matthew A Cottam, Hanbing An

Pageof 5

Frequent Collaborators

8 joint publications

Nathan C Winn

5 joint publications

Matthew A Cottam

5 joint publications

Kathryn E Wellen

5 joint publications

Jeffrey C Rathmell